Animal tuberculosis (TB) attributable to Mycobacterium tuberculosis complicated (MTC) micro organism stays as some of the vital infectious ailments of livestock, regardless of a long time of eradication applications and analysis efforts, in an period the place the livestock sector is amongst a very powerful and quickly increasing industrial agricultural segments worldwide. This work offers a worldwide overview of the spatial and temporal tendencies of reported scientific data of TB in livestock, aiming to achieve insights into analysis subtopics throughout the animal TB epidemiology area and to focus on territorial inequalities concerning information reporting and analysis outputs over time. To ship such data, peer-reviewed studies of TB research in livestock had been retrieved from the Internet of Science and Google Scholar, systematized, and dissected.
The validated dataset contained 443 prevalence observations, protecting the 1981-2020 interval (39 years). We spotlight a transparent transfer in the direction of transdisciplinary areas and the One Well being method, with a worldwide temporal improve of publications combining livestock with wildlife and/or human parts, which replicate the significance of non-prototypical hosts as key to understanding animal TB. It turns into evident that cattle is the principle host throughout works from all continents, nonetheless many areas stay poorly surveyed.
Read Latest Articles: https://www.tbdb.org/how-accurate-are-covid-19-pcr-tests/
TB analysis in livestock in low-/middle-income international locations is markedly rising, reflecting modifications in animal husbandry, but in addition mirroring the globalization period, with a marked improve in worldwide collaboration and capacitation applications for scientific and technological improvement. This overview offers an outline of probably the most prolific continents, international locations, and analysis fields in animal TB epidemiology, clearly outlining data gaps and key precedence subjects. The estimated development pattern of livestock manufacturing till 2050, notably in Asia and Africa, in response to human inhabitants development and animal-protein demand, would require additional funding in early surveillance and adaptive analysis to accommodate the upper range of livestock species and MTC members and elevating the likelihood to finetune funding schemes.
Can a tuberculosis analysis program promoted by a scientific society contribute to the management of the illness?
Though Spain is a developed nation, Tuberculosis (TB) was for years a illness with excessive incidence charges in comparison with different European international locations, a state of affairs that worsened with the HIV/AIDS epidemic and with the rise of immigration. The Spanish Respiratory Society (SEPAR) created in 2004 the Built-in Analysis Applications (PII) on respiratory ailments, together with TB (PII-TB) which has carried out research associated to the 5 traces of analysis that it maintains: medical / epidemiological, microbiological, technological/medical administration, evaluative, and worldwide cooperation.
Following the suggestions on the need to guage well being applications made by worldwide organizations, the analysis of PII-TB was not too long ago carried out, revealing the state of affairs of the principle variables of the illness and their evolution over the time that this system has been working. PII-TB has generated considerable information on the state of affairs of this illness in our nation in years when this data has been restricted. The truth that the outcomes of the research have been extensively disseminated makes it simpler for all professionals concerned within the prevention, prognosis and remedy of TB to implement and/or to enhance actions that, lastly, will contribute to the management of this illness.
A pesar de que España es un país desarrollado, la tuberculosis (TB) fue durante años una enfermedad con importantes tasas de incidencia con respecto a otros países europeos, situación que empeoró con la epidemia del VIH/SIDA y el aumento de la inmigración. Como consecuencia de la situación, SEPAR crea en el año 2004 los Programas Integrados de Investigación (PII), entre los que se incluye la TB (PII-TB). Dicho programa ha llevado a cabo estudios relacionados con alguna de las cinco líneas de investigación que éste mantiene: clínica/epidemiológica, microbiológica, tecnológica/gestión clínica, evaluativa y de cooperación internacional.
Siguiendo las recomendaciones sobre la necesidad de evaluar los programas de salud que hacen los organismos internacionales, se realizó recientemente la evaluación del PII-TB, lo que ha permitido conocer la situación de las principales variables de la enfermedad a lo largo de los años de funcionamiento del programa y la evolución de las mismas. El PII-TB ha generado abundantes datos sobre la situación de esta enfermedad en nuestro país durante unos años en que esta información ha sido limitada. El hecho de que los resultados de los estudios hayan sido extensamente difundidos, facilita que todos los profesionales implicados en la prevención, diagnóstico y tratamiento de la TB puedan implementar y/o mejorar last actividades que, en definitiva, contribuirán a mejorar el management de esta enfermedad.
Superior imaging instruments for childhood tuberculosis: potential purposes and analysis wants
Tuberculosis is the main explanation for loss of life globally that is because of a single pathogen, and as much as a fifth of sufferers with tuberculosis in high-incidence international locations are youngsters youthful than 16 years. Sadly, the prognosis of childhood tuberculosis is difficult as a result of the illness is commonly paucibacillary and it’s troublesome to acquire appropriate specimens, inflicting poor sensitivity of at the moment accessible pathogen-based checks.
Chest radiography is essential for diagnostic evaluations as a result of it detects abnormalities per childhood tuberculosis, however a number of limitations exist within the interpretation of such outcomes. Subsequently, different imaging strategies have to be systematically evaluated in youngsters with tuberculosis, though present information counsel that when accessible, cross-sectional imaging, comparable to CT, needs to be thought-about within the diagnostic analysis for tuberculosis in a symptomatic youngster.
Moreover, a lot of the understanding of childhood tuberculosis stems from medical specimens that may not precisely signify the lesional biology at an infection websites. By offering non-invasive measures of lesional biology, superior imaging instruments might improve the understanding of fundamental biology and enhance on the poor sensitivity of present pathogen detection methods.
) Mycobacterium tuberculosis 16kD (M. tuberculosis) |
|
MBS6011625-5x1mg |
MyBiosource |
5x1mg |
EUR 5675 |
 M. tuberculosis |
|
5172 |
Virostat |
100 ug |
EUR 270 |
|
Description: CFP10 |
M. tuberculosis |
|
5175 |
Virostat |
100 ug |
EUR 270 |
|
Description: 16 kDa |
M. tuberculosis |
|
5176 |
Virostat |
100 ug |
EUR 270 |
|
Description: 16 kDa |
M. tuberculosis |
|
5177 |
Virostat |
100 ug |
EUR 270 |
|
Description: Hsp65 |
M. tuberculosis |
|
5178 |
Virostat |
100 ug |
EUR 270 |
|
Description: Hsp65 |
M. tuberculosis |
|
8811 |
Virostat |
100 ug |
EUR 340 |
|
Description: 38 kDa |
M. tuberculosis |
|
4601 |
Virostat |
1 ml |
EUR 235 |
|
|
|
Description: all antigens |
 Antibody) Mycobacterium tuberculosis (M. tuberculosis) Antibody |
|
abx415707-1ml |
Abbexa |
1 ml |
EUR 727.2 |
|
|
Mycobacterium tuberculosis (M. tuberculosis) Antibody |
|
abx415707-200l |
Abbexa |
200 µl |
EUR 537.5 |
 M. Tuberculosis HSP70 Protein |
|
abx060544-100ug |
Abbexa |
100 ug |
EUR 1378.8 |
|
|
 Mycobacterium tuberculosis, HSP, Recombinant |
|
MBS636978-01mg |
MyBiosource |
0.1mg |
EUR 735 |
Mycobacterium tuberculosis, HSP, Recombinant |
|
MBS636978-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3165 |
 (PE)) Mycobacterium tuberculosis 16kD (M. tuberculosis) (PE) |
|
MBS6129466-01mL |
MyBiosource |
0.1(mL |
EUR 1240 |
Mycobacterium tuberculosis 16kD (M. tuberculosis) (PE) |
|
MBS6129466-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5430 |
Mycobacterium tuberculosis 16kD (M. tuberculosis) (PE) |
|
MBS6129467-01mL |
MyBiosource |
0.1(mL |
EUR 1095 |
Mycobacterium tuberculosis 16kD (M. tuberculosis) (PE) |
|
MBS6129467-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4775 |
 (AP)) Mycobacterium tuberculosis 16kD (M. tuberculosis) (AP) |
|
MBS6126370-01mL |
MyBiosource |
0.1(mL |
EUR 1240 |
Mycobacterium tuberculosis 16kD (M. tuberculosis) (AP) |
|
MBS6126370-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5430 |
Mycobacterium tuberculosis 16kD (M. tuberculosis) (AP) |
|
MBS6126371-01mL |
MyBiosource |
0.1(mL |
EUR 1095 |
Mycobacterium tuberculosis 16kD (M. tuberculosis) (AP) |
|
MBS6126371-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4775 |
 (HRP)) Mycobacterium tuberculosis 16kD (M. tuberculosis) (HRP) |
|
MBS6128846-01mL |
MyBiosource |
0.1(mL |
EUR 1240 |
Mycobacterium tuberculosis 16kD (M. tuberculosis) (HRP) |
|
MBS6128846-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5430 |
Mycobacterium tuberculosis 16kD (M. tuberculosis) (HRP) |
|
MBS6128847-01mL |
MyBiosource |
0.1(mL |
EUR 1095 |
Mycobacterium tuberculosis 16kD (M. tuberculosis) (HRP) |
|
MBS6128847-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4775 |
 (APC)) Mycobacterium tuberculosis 16kD (M. tuberculosis) (APC) |
|
MBS6126990-01mL |
MyBiosource |
0.1(mL |
EUR 1240 |
Mycobacterium tuberculosis 16kD (M. tuberculosis) (APC) |
|
MBS6126990-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5430 |
Mycobacterium tuberculosis 16kD (M. tuberculosis) (APC) |
|
MBS6126991-01mL |
MyBiosource |
0.1(mL |
EUR 1095 |
Mycobacterium tuberculosis 16kD (M. tuberculosis) (APC) |
|
MBS6126991-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4775 |
 (FITC)) Mycobacterium tuberculosis 16kD (M. tuberculosis) (FITC) |
|
MBS6128225-01mL |
MyBiosource |
0.1(mL |
EUR 1240 |
Mycobacterium tuberculosis 16kD (M. tuberculosis) (FITC) |
|
MBS6128225-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5430 |
Mycobacterium tuberculosis 16kD (M. tuberculosis) (FITC) |
|
MBS6128226-01mL |
MyBiosource |
0.1(mL |
EUR 1095 |
Mycobacterium tuberculosis 16kD (M. tuberculosis) (FITC) |
|
MBS6128226-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4775 |
 Recombinant M. Tuberculosis HSP65 |
|
DAGA-194 |
Creative Diagnostics |
0.1 mg |
Ask for price |
|
|
|
Description: Recombinant |
 (Biotin)) Mycobacterium tuberculosis 16kD (M. tuberculosis) (Biotin) |
|
MBS6127611-01mL |
MyBiosource |
0.1(mL |
EUR 1240 |
Mycobacterium tuberculosis 16kD (M. tuberculosis) (Biotin) |
|
MBS6127611-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5430 |
Mycobacterium tuberculosis 16kD (M. tuberculosis) (Biotin) |
|
MBS6127612-01mL |
MyBiosource |
0.1(mL |
EUR 1095 |
Mycobacterium tuberculosis 16kD (M. tuberculosis) (Biotin) |
|
MBS6127612-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4775 |
 Recombinant Mycobacterium Tuberculosis HSP Protein |
|
VAng-Yyj0063-10g |
Creative Biolabs |
10 µg |
EUR 2250 |
|
Description: Mycobacterium Tuberculosis, HSP, recombinant protein. |
 MAb to M. tuberculosis |
|
MBS310270-1mg |
MyBiosource |
1mg |
EUR 955 |
MAb to M. tuberculosis |
|
MBS310270-5x1mg |
MyBiosource |
5x1mg |
EUR 4115 |
MAb to M. tuberculosis |
|
MBS310271-1mg |
MyBiosource |
1mg |
EUR 1035 |
MAb to M. tuberculosis |
|
MBS310271-5x1mg |
MyBiosource |
5x1mg |
EUR 4485 |
MAb to M. tuberculosis |
|
MBS310272-1mg |
MyBiosource |
1mg |
EUR 1035 |
MAb to M. tuberculosis |
|
MBS310272-5x1mg |
MyBiosource |
5x1mg |
EUR 4485 |
MAb to M. tuberculosis |
|
MBS310273-1mg |
MyBiosource |
1mg |
EUR 1035 |
MAb to M. tuberculosis |
|
MBS310273-5x1mg |
MyBiosource |
5x1mg |
EUR 4485 |
 Rabbit A' M. tuberculosis |
|
MBS315160-1mL |
MyBiosource |
1mL |
EUR 855 |
Rabbit A' M. tuberculosis |
|
MBS315160-5x1mL |
MyBiosource |
5x1mL |
EUR 3685 |
Rabbit A' M. tuberculosis |
|
MBS315161-1mL |
MyBiosource |
1mL |
EUR 915 |
Rabbit A' M. tuberculosis |
|
MBS315161-5x1mL |
MyBiosource |
5x1mL |
EUR 3945 |
Rabbit A' M. tuberculosis |
|
MBS315162-1mL |
MyBiosource |
1mL |
EUR 915 |
Rabbit A' M. tuberculosis |
|
MBS315162-5x1mL |
MyBiosource |
5x1mL |
EUR 3945 |
Rabbit A' M. tuberculosis |
|
MBS315163-1mL |
MyBiosource |
1mL |
EUR 800 |
Rabbit A' M. tuberculosis |
|
MBS315163-5x1mL |
MyBiosource |
5x1mL |
EUR 3420 |
 Mycobacterium tuberculosis HSP 70 Recombinant Protein |
|
53-349 |
ProSci |
0.01 mg |
EUR 789.9 |
|
Description: Mycobacterium tuberculosis HSP 70 Recombinant Protein |
 M. Tuberculosis TB22.2 Antigen |
|
DAGA-186 |
Creative Diagnostics |
100 µg |
EUR 665.44 |
|
|
|
Description: Recombinant |
 M. tuberculosis CFP10, Recomb. |
|
MBS319838-01mg |
MyBiosource |
0.1mg |
EUR 755 |
M. tuberculosis CFP10, Recomb. |
|
MBS319838-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3165 |
 M. tuberculosis Moex protein |
|
MBS596054-1mg |
MyBiosource |
1mg |
EUR 425 |
M. tuberculosis Moex protein |
|
MBS596054-2mg |
MyBiosource |
2mg |
EUR 700 |
M. tuberculosis Moex protein |
|
MBS596054-5mg |
MyBiosource |
5mg |
EUR 1505 |
 M. Tuberculosis Mpt70 Antigen |
|
DAGA-182 |
Creative Diagnostics |
100 µg |
EUR 665.44 |
|
|
|
Description: Recombinant |
 M. Tuberculosis MPT83 Antigen |
|
DAGA-183 |
Creative Diagnostics |
100 µg |
EUR 665.44 |
|
|
|
Description: Recombinant |
 M. Tuberculosis Mpt64 Antigen |
|
DAGA-184 |
Creative Diagnostics |
100 µg |
EUR 665.44 |
|
|
|
Description: Recombinant |
 M. tuberculosis CFP10 Protein |
|
abx061400-100g |
Abbexa |
100 µg |
Ask for price |
 M. tuberculosis CFP10, Protein |
|
abx061400-100ug |
Abbexa |
100 ug |
EUR 961.2 |
|
|
M. tuberculosis CFP10 Protein |
|
abx061400-10g |
Abbexa |
10 µg |
EUR 1100 |
M. tuberculosis CFP10 Protein |
|
abx061400-50g |
Abbexa |
50 µg |
Ask for price |
 M. tuberculosis ESAT6, Protein |
|
abx061402-100ug |
Abbexa |
100 ug |
EUR 910.8 |
|
|
 M. Tuberculosis Rv2672 Antigen |
|
DAGA-174 |
Creative Diagnostics |
100 µg |
EUR 665.44 |
|
|
|
Description: Recombinant |
 M. Tuberculosis Rv2253 Antigen |
|
DAGA-177 |
Creative Diagnostics |
100 µg |
EUR 665.44 |
|
|
|
Description: Recombinant |
 M. Tuberculosis MT3413 Antigen |
|
DAGA-178 |
Creative Diagnostics |
100 µg |
EUR 665.44 |
|
|
|
Description: Recombinant |
 M. Tuberculosis Rv0477 Antigen |
|
DAGA-179 |
Creative Diagnostics |
100 µg |
EUR 665.44 |
|
|
|
Description: Recombinant |
 IgG) Monoclonal Anti-M. tuberculosis Heat Shock Protein 65 (hsp65/groEL-2/Cpn60-2) IgG |
|
HSP651-M |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
 M. Tuberculosis Rv0192A Antigen |
|
DAGA-173 |
Creative Diagnostics |
100 µg |
EUR 665.44 |
|
|
|
Description: Recombinant |
 M. Tuberculosis Rv0398c Antigen |
|
DAGA-176 |
Creative Diagnostics |
100 µg |
EUR 665.44 |
|
|
|
Description: Recombinant |
 Antibody) Mycobacterium tuberculosis 38 kDa Antigen (M. tuberculosis 38 kDa) Antibody |
|
abx411025-02mg |
Abbexa |
0.2 mg |
EUR 678 |
|
|
Mycobacterium tuberculosis 38 kDa Antigen (M. tuberculosis 38 kDa) Antibody |
|
abx411025-100g |
Abbexa |
100 µg |
EUR 487.5 |
 Antibody) Mycobacterium tuberculosis 16 kDa Antigen (M. tuberculosis 16 kDa) Antibody |
|
abx415759-01mg |
Abbexa |
0.1 mg |
EUR 760.8 |
|
|
Mycobacterium tuberculosis 16 kDa Antigen (M. tuberculosis 16 kDa) Antibody |
|
abx415759-200l |
Abbexa |
200 µl |
EUR 600 |
 Mab to M. tuberculosis MPT64 |
|
MBS313702-1mg |
MyBiosource |
1mg |
EUR 515 |
Mab to M. tuberculosis MPT64 |
|
MBS313702-5x1mg |
MyBiosource |
5x1mg |
EUR 2135 |
Mab to M. tuberculosis MPT64 |
|
MBS313703-1mg |
MyBiosource |
1mg |
EUR 515 |
Mab to M. tuberculosis MPT64 |
|
MBS313703-5x1mg |
MyBiosource |
5x1mg |
EUR 2135 |
Mab to M. tuberculosis MPT64 |
|
MBS313704-1mg |
MyBiosource |
1mg |
EUR 515 |
Mab to M. tuberculosis MPT64 |
|
MBS313704-5x1mg |
MyBiosource |
5x1mg |
EUR 2135 |
Mab to M. tuberculosis MPT64 |
|
MBS313705-1mg |
MyBiosource |
1mg |
EUR 515 |
Mab to M. tuberculosis MPT64 |
|
MBS313705-5x1mg |
MyBiosource |
5x1mg |
EUR 2135 |
 M. tuberculosis MPT64 Rec. Ag |
|
MBS313721-1mg |
MyBiosource |
1mg |
EUR 515 |
M. tuberculosis MPT64 Rec. Ag |
|
MBS313721-5x1mg |
MyBiosource |
5x1mg |
EUR 2155 |
M. tuberculosis MPT64 Rec. Ag |
|
MBS313722-1mg |
MyBiosource |
1mg |
EUR 515 |
M. tuberculosis MPT64 Rec. Ag |
|
MBS313722-5x1mg |
MyBiosource |
5x1mg |
EUR 2155 |
 MAb to M. tuberculosis, 16kDa |
|
MBS310461-1mg |
MyBiosource |
1mg |
EUR 605 |
MAb to M. tuberculosis, 16kDa |
|
MBS310461-5x1mg |
MyBiosource |
5x1mg |
EUR 2640 |
 MAb to M. tuberculosis, 38kDa |
|
MBS310523-1mg |
MyBiosource |
1mg |
EUR 605 |
MAb to M. tuberculosis, 38kDa |
|
MBS310523-5x1mg |
MyBiosource |
5x1mg |
EUR 2640 |
 MAb to M. tuberculosis CFP10 |
|
MBS312553-1mg |
MyBiosource |
1mg |
EUR 805 |
MAb to M. tuberculosis CFP10 |
|
MBS312553-5x1mg |
MyBiosource |
5x1mg |
EUR 3455 |
MAb to M. tuberculosis CFP10 |
|
MBS312555-1mg |
MyBiosource |
1mg |
EUR 805 |
MAb to M. tuberculosis CFP10 |
|
MBS312555-5x1mg |
MyBiosource |
5x1mg |
EUR 3455 |
 Recombinant M. tuberculosis 38kD |
|
DAG-WT1091 |
Creative Diagnostics |
1 mg |
EUR 480 |
|
|
|
Description: Recombinant |
 M. tuberculosis, 38kDa, Recombinant |
|
MBS319392-01mg |
MyBiosource |
0.1mg |
EUR 1150 |
M. tuberculosis, 38kDa, Recombinant |
|
MBS319392-5x01mg |
MyBiosource |
5x0.1mg |
EUR 4995 |
 M. Tuberculosis 85-C Antigen |
|
DAGA-175 |
Creative Diagnostics |
100 µg |
EUR 749.7 |
|
|
|
Description: Recombinant |
 M. Tuberculosis 85-A Antigen |
|
DAGA-181 |
Creative Diagnostics |
100 µg |
EUR 665.44 |
|
|
|
Description: Recombinant |
 M. Tuberculosis 85-B Antigen |
|
DAGA-185 |
Creative Diagnostics |
100 µg |
EUR 665.44 |
|
|
|
Description: Recombinant |
 M. Tuberculosis 48 kDa protein |
|
DAGA-191 |
Creative Diagnostics |
1 mg |
Ask for price |
|
|
|
Description: Recombinant |
 M. Tuberculosis 38 kDa Protein |
|
abx060636-100g |
Abbexa |
100 µg |
Ask for price |
M. Tuberculosis 38 kDa Protein |
|
abx060636-100ug |
Abbexa |
100 ug |
EUR 978 |
|
|
M. Tuberculosis 38 kDa Protein |
|
abx060636-10g |
Abbexa |
10 µg |
EUR 1437.5 |
M. Tuberculosis 38 kDa Protein |
|
abx060636-50g |
Abbexa |
50 µg |
Ask for price |
) Heat Shock Protein 65, Recombinant, Mycobacterium tuberculosis (HSP65) |
|
MBS636130-0002mg |
MyBiosource |
0.002mg |
EUR 390 |
Heat Shock Protein 65, Recombinant, Mycobacterium tuberculosis (HSP65) |
|
MBS636130-001mg |
MyBiosource |
0.01mg |
EUR 540 |
Heat Shock Protein 65, Recombinant, Mycobacterium tuberculosis (HSP65) |
|
MBS636130-5x001mg |
MyBiosource |
5x0.01mg |
EUR 2275 |
 M. Tuberculosis 85A Antigen[his] |
|
DAGA-189 |
Creative Diagnostics |
10 µg |
EUR 618.19 |
|
|
|
Description: Recombinant |
 M. Tuberculosis 85A Antigen [His] |
|
DAGA-192 |
Creative Diagnostics |
50 µg |
EUR 834.75 |
|
|
|
Description: Recombinant |
 M. Tuberculosis ESAT-6 Antigen |
|
DAGA-187 |
Creative Diagnostics |
100 µg |
EUR 665.44 |
|
|
|
Description: Recombinant |
 Purified) Anti-Tb7.7 (M. tuberculosis) Purified |
|
11-190-C100 |
ExBio |
0.1 mg |
EUR 198 |
|
|
 M. Tuberculosis Mpt63/MPB63 Antigen |
|
DAGA-180 |
Creative Diagnostics |
100 µg |
EUR 665.44 |
|
|
|
Description: Recombinant |
Anti-Tb7.7 (M. tuberculosis) Purified |
|
MBS1801449-01mg |
MyBiosource |
0.1mg |
EUR 305 |
Anti-Tb7.7 (M. tuberculosis) Purified |
|
MBS1801449-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1120 |
 Purified) Anti-Acr1 (M. tuberculosis) Purified |
|
11-185-C100 |
ExBio |
0.1 mg |
EUR 198 |
|
|
 Purified) Anti-Tb10.4 (M. tuberculosis) Purified |
|
11-186-C100 |
ExBio |
0.1 mg |
EUR 198 |
|
|
 Purified) Anti-Tb10.3 (M. tuberculosis) Purified |
|
11-187-C100 |
ExBio |
0.1 mg |
EUR 198 |
|
|
 Purified) Anti-Acr2 (M. tuberculosis) Purified |
|
11-188-C100 |
ExBio |
0.1 mg |
EUR 198 |
|
|
 Purified) Anti-GlcB (M. tuberculosis) Purified |
|
11-192-C100 |
ExBio |
0.1 mg |
EUR 198 |
|
|
 Recombinant M. Tuberculosis CFP-10 |
|
DAGA-170 |
Creative Diagnostics |
1 mg |
EUR 756 |
|
|
|
Description: Recombinant |
Anti-Acr1 (M. tuberculosis) Purified |
|
MBS1801444-01mg |
MyBiosource |
0.1mg |
EUR 305 |
Anti-Acr1 (M. tuberculosis) Purified |
|
MBS1801444-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1120 |
Anti-Tb10.4 (M. tuberculosis) Purified |
|
MBS1801445-01mg |
MyBiosource |
0.1mg |
EUR 305 |
Anti-Tb10.4 (M. tuberculosis) Purified |
|
MBS1801445-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1120 |
Anti-Tb10.3 (M. tuberculosis) Purified |
|
MBS1801446-01mg |
MyBiosource |
0.1mg |
EUR 305 |
Anti-Tb10.3 (M. tuberculosis) Purified |
|
MBS1801446-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1120 |
Anti-Acr2 (M. tuberculosis) Purified |
|
MBS1801447-01mg |
MyBiosource |
0.1mg |
EUR 305 |
Anti-Acr2 (M. tuberculosis) Purified |
|
MBS1801447-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1120 |
Anti-GlcB (M. tuberculosis) Purified |
|
MBS1801450-01mg |
MyBiosource |
0.1mg |
EUR 305 |
Anti-GlcB (M. tuberculosis) Purified |
|
MBS1801450-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1120 |
 Purified) Anti-Ag85b (M. tuberculosis) Purified |
|
11-189-C100 |
ExBio |
0.1 mg |
EUR 198 |
|
|
Anti-Ag85b (M. tuberculosis) Purified |
|
MBS1801448-01mg |
MyBiosource |
0.1mg |
EUR 305 |
Anti-Ag85b (M. tuberculosis) Purified |
|
MBS1801448-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1120 |
 M. Tuberculosis 63 kDa protein [His] |
|
DAGA-190 |
Creative Diagnostics |
1 mg |
Ask for price |
|
|
|
Description: Recombinant |
 Bacteria-Derived tuberculosis HSP 70 Recombinant Protein liquid |
|
IBCTMYCBCTTBHSP70R10UG |
Innovative research |
each |
EUR 948 |
|
|
|
Description: Bacteria-Derived tuberculosis HSP 70 Recombinant Protein liquid |
Bacteria-Derived tuberculosis HSP 70 Recombinant Protein liquid |
|
MBS8430610-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
 Zmp1 M. tuberculosis Recombinant Protein |
|
90-361 |
ProSci |
50 ug |
EUR 752.1 |
|
Description: M13 endopeptidases are single-pass, transmembrane zinc-metallopeptidases responsible in human for the regulation of the biological activity of many hormones and peptides and are involved in many important processes such as blood pressure regulation (Neprilysin or NEP1), cardiovascular development (Endothelin Converting Enzyme-1 or ECE-12), prevention of haemolytic reaction (KELL) and phosphate homeostasis (PHEX). Zmp1 is a soluble enzyme member of the M13 endopeptidases family that plays a key role in Mycobacterium tuberculosis pathogenicity with a still unknown mechanism. Recently, it was shown to suppress inflammasome activation by inhibiting caspase-1 activation, thus preventing processing of pro-IL-1beta into IL-1beta and the consequent phagosome maturation. |
 Recombinant M. Tuberculosis Moex antigen |
|
DAGA-213 |
Creative Diagnostics |
1 mg |
Ask for price |
|
|
|
Description: Native |
 (CFP10) Antigen) M. Tuberculosis EsxB (LHP) (CFP10) Antigen |
|
DAGA-188 |
Creative Diagnostics |
100 µg |
EUR 665.44 |
|
|
|
Description: Recombinant |
 Myobacterium Tuberculosis Heat Shock Protein 65 Protein |
|
20-abx263477 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
|
Myobacterium Tuberculosis Heat Shock Protein 65 Protein |
|
abx263477-10mg |
Abbexa |
10 mg |
EUR 1362.5 |
Myobacterium Tuberculosis Heat Shock Protein 65 Protein |
|
abx263477-1mg |
Abbexa |
1 mg |
EUR 225 |
Myobacterium Tuberculosis Heat Shock Protein 65 Protein |
|
abx263477-5mg |
Abbexa |
5 mg |
EUR 325 |
 M. Tuberculosis ClpP Protease Assay Kit |
|
TBP100K |
ProFoldin |
100 assays |
EUR 292.32 |
|
Description: This product includes 3100 ul of Assay Buffer and 310 ul of 10 x Substrate and 3500 ul of Stop solution. It is for 100 assays in 384-well plate format |
 Mouse antibody for M. tuberculosis ESAT6 |
|
5173 |
Virostat |
100 ug |
EUR 386.26 |
|
Description: This is purified Mouse monoclonal antibody against M tuberculosis ESAT6 for WB, ELISA. |
 Mouse antibody for M. tuberculosis 38kDa |
|
5174 |
Virostat |
100 ug |
EUR 386.26 |
|
Description: This is purified Mouse monoclonal antibody against M tuberculosis 38kDa for WB, ELISA. |
 Purified) Anti-CFP-10 (M. tuberculosis) Purified |
|
11-490-C025 |
ExBio |
0.025 mg |
EUR 99 |
Anti-CFP-10 (M. tuberculosis) Purified |
|
11-490-C100 |
ExBio |
0.1 mg |
EUR 198 |
|
|
 Purified) Anti-ESAT-6 (M. tuberculosis) Purified |
|
11-491-C025 |
ExBio |
0.025 mg |
EUR 99 |
Anti-ESAT-6 (M. tuberculosis) Purified |
|
11-491-C100 |
ExBio |
0.1 mg |
EUR 198 |
|
|
) Recombinant M. tuberculosis CFP10 (No tag) |
|
DAG-WT1769 |
Creative Diagnostics |
1 mg |
EUR 1460 |
|
|
|
Description: Recombinant |
Lastly, there are key data gaps concerning using imaging instruments for childhood tuberculosis that we outlined on this Private View, along with a proposed roadmap for future analysis.
